Ethane exhalation was measured in 42 control
Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers P Letteron, V Duchatelle, A Berson, B Fromenty, C Fisch, C Degott, J P Benhamou, D Pessayre Abstract Ethane exhalation was measured in 42 control subjects, 52 patients with various non-alcoholic liver diseases, and 89 alcohol abusers who had been admitted to hospital for alcohol withdrawal and assessment ofliver disease (six with normal liver tests, 10 with steatosis with or without fibrosis, six with alcoholic hepatitis, 29 with cirrhosis, 34 with both cirrhosis and alcoholic hepatitis, and four with both cirrhosis and a hepatocellular carcinoma). Ethane exhalation was similar in control subjects and in patients with non-alcoholic liver diseases, but was five times higher in alcohol abusers. Ethane exhalation in alcohol abusers was significantly, but very weakly, correlated with the daily ethanol intake before hospital admission, and the histological score for steatosis, but not with the inflammation or alcoholic hepatitis scores. Ethane exhalation was inversely correlated with the duration of abstinence before the test. In nine alcoholic patients, the exhalation of ethane was measured repeatedly, and showed slow improvement during abstinence. Ethane exhalation was significantly but weakly correlated with the Pugh's score in patients with alcoholic cirrhosis. It is concluded that the mean ethane exhalation is increased in alcohol abusers. One of the possible mechanisms may be the presence of oxidizable fat in the liver. The weak correlation with the Pugh's score is consistent with the contribution of many other factors in the progression to severe liver disease. (Gut 1993; 34: [409] [410] [411] [412] [413] [414] Experimental data support a role of free radical mechanisms, including lipid peroxidation, in ethanol induced cellular injury in animals. ' The question of whether lipid peroxidation occurs in alcoholic patients, however, and if it does of its possible mechanism(s) and importance in the development of liver lesions, remains largely unanswered at present. Hepatic levels of conjugated dienes (an early product of lipid peroxidation) were found to be higher in 16 patients with alcoholic liver disease than in eight patients with non-alcoholic liver disease.2 Hepatic thiobarbituric acid reactants (malondialdehyde and other products of lipid peroxidation) were higher in 13 heavy drinkers with fatty livers (studied after about seven days of abstinence) than in five non-drinkers with histologically normal livers.3 In another study, serum and hepatic thiobarbituric acid reactive substances were found to be slightly increased in patients with chronic liver diseases, but did not show any difference between patients with chronic alcoholic liver disease and patients with chronic non-alcoholic liver disease.4
Peroxidation may also be assessed noninvasively by determining the exhalation of volatile hydrocarbons (pentane and ethane) in breath.5 Pentane and ethane are formed during the process of lipid peroxidation and are exhaled in breath (see Discussion). A difficulty with pentane is that it is extensively oxidised in the liver.56 In patients with liver disease, therefore, an increased exhalation of pentane may mean either an increased production rate (peroxidation), or a decreased hepatic metabolism.5 In contrast, ethane undergoes little hepatic metabolism, so that its exhalation mainly reflects its formation rate.5 An increased exhalation of pentane, but not of ethane, was found in 15 patients with alcoholic cirrhosis compared with 21 healthy controls.7 The duration of abstinence before breath sampling, however, was not mentioned.7
Yet another method of assessing in vivo lipid peroxidation is the measurement of serum vitamin E concentrations (vitamin E is consumed during peroxidation). Serum vitamin E concentrations, however depend on several other factors, including diet, absorption of this fat soluble vitamin, and serum lipid values.8`0 A decreased serum vitamin E concentration in chronic alcoholic patients has been found in two studies." 12 In another study, however, the serum vitamin E/serum cholesterol ratio was found to be normal in 21 of 25 patients with chronic alcoholic liver disease. 13 The reasons for the apparent discrepancies in tests of lipid peroxidation in alcoholic patients in the published reports are not completely understood. They may include the inconsistant occurrence of lipid peroxidation in alcoholics, the small numbers of patients studied, differences in the liver diseases studied, and failure to take account of the duration of abstinence before the various measurements.
In 
MEASUREMENT OF ETHANE EXHALATION
Smokers were asked to abstain from smoking for 3 hours before the test. After explanation and acceptation of the test, the subjects were asked to first exhale normally, and then to exhale forcefully into an empty 2-5 litre gas sampling bag, thus providing alveolar air.7 Another bag was filled with ambiant air from the room to measure the concentration of ethane in the air inhaled by the subject.7
The concentration of ethane in air was measured as previously reported by Letteron et al,4 by gas-liquid chromatography apparatus (Packard model 437 A), equipped with a flame ionisation detector. Peak areas were integrated and calculated on a Packard recorder (model 604) with a range set at 1 and an attenuation factor set at 1 (no attenuation). Briefly, samples of air were injected through a six-way valve and a 5 ml sample loop, in a 100 x 0 16 cm id stainless steel column packed with Carbosieve G (60/80 mesh). The column and detector temperatures were set at 170°C and 200°C, respectively. The flow rate of nitrogen was set at 20 ml/minute. Under these conditions, the retention time of ethane was about 3 minutes. Standard dilutions of pure ethane (Air Liquide, France) in air gave linear responses over a range of concentrations that exceeded both ways the range of concentrations observed in the test samples. For each test, a standard calibration was made with a dilution of ethane (8500 pmol/l air). The ethane exhaled by the subjects was calculated as the difference between the concentration of ethane in the air exhaled by the subject and that in the air inhaled (means of three injections from each gas sampling bag). The intraassay coefficient of variation was less than 10%.
STATISTICS
Mean ethane exhalation in the three different groups of subjects -that is, healthy subjects, non-alcoholic patients, and alcohol abusers -was compared by one way analysis of variance followed by Dunnett's t test. Univariate regression analysis was performed to assess possible relationships between ethane exhalation and the various parameters examined.
Results
Ethane exhalation was not different in the 42 healthy subjects and the 52 patients with nonalcoholic liver diseases (Fig 1) . Ethane exhalation did not differ by analysis of variance among the various subgroups composing the nonalcoholic group (Table I ). In contrast, the exhalation of ethane was significantly increased in the 89 alcohol abusers (Fig 1) , the mean value in this group being fivefold that found in healthy subjects. The exhalation of ethane in the 89 alcohol abusers was significantly but very weakly correlated with the acknowledged daily intake of Ethane exhalation was invet with the duration of abstinence the time interval between the o admission and the first measure exhalation (Fig 3) . In nine pai ethane exhalation measuremen Table II) was followed by rep ments (Fig 3) . In all of theso exhalation of ethane decreased w of hospital stay, and thus abst This decrease was usually s occurring over a period of severa
Discussion
The initial step in lipid pero: abstraction, by a drug free radic Our results establish, in a large series, that ransferase, the the average exhalation of ethane is indeed LT activities, or appreciably increased in alcohol abusers exhalation was admitted to hospital (Fig 1) . These results -related with the are consistent with several previous reports, ic patients with showing changes in other markers of lipid hout alcoholic peroxidation in chronic alcoholic patients2"" 12 oma) (Fig 2) .
but contrast with the report of normal ethane to show any exhalation in 15 patients with alcoholic ha1re exhalation cirrhosis.7 The reasons for this discrepancy are ical subgroups unknown. Five of the latter patients had been exhalation was abstinent for at least 1 month before admission to rrelated with the hospital.7 The other patients had been drinking Lcuolar steatosis until admission, but the time between admission with any of the and the measurement of breath ethane was not ntitated by the indicated.7 This interval may have been prowith the global longed if patients were included only after the ,lobal alcoholic results of other tests had been returned (such as liver pathology, ultrasonography). rsely correlated At least three mechanisms whereby the meta-, as assessed by bolism of ethanol may lead to formation of free unset of hospital radicals and peroxidation have been pro--ment of ethane posed.'5-2' These are as follows: tients, the first (a) Firstly, cytochrome P450 partly transIt (reported in forms ethanol into the a-hydroxyethyl radical )eated measure-(.CHOH-CH3). '5-17 ,e patients, the (b) Secondly, ethanol administration partly 'ith the duration converts xanthine dehydrogenase to xanthine tinence (Fig 3) . oxidase.'5 Xanthine oxidase metabolises slow, however, acetaldehyde, producing superoxide anion.'9 l weeks (Fig 3) . Superoxide anion may release ferrous iron from ferritin, producing the hydroxyl radical, and initiating lipid peroxidation. Increased ethane exhalation observed during the first week(s) of abstinence may, however, be (Fig 1) , possible causes should be sought in lesions more specifically associated with alcohol ingestion.
A major abnormality characteristically (if not exclusively) associated with alcoholism is the presence of polymorphonuclear cells in the inflammatory infiltrate. Polymorphonuclear cells are activated at sites of inflammation and release superoxide anion.22 However, they also release the iron binding protein, lactoferrin, which limits the extracellular formation of the hydroxyl radical.22 Stimulated human polymorphonuclear leukocytes do not cause peroxidation, unless iron salts are added to the medium.23 Instead, their toxicity to hepatocytes seems related to the release of proteases.24 In the present study, there was no relationship between the exhalation of ethane and the semi-quantitative assessment of the inflammatory infiltrate.
A second lesion, which is rather characteristic of alcoholic liver disease is steatosis. Fat present in the liver may serve as a substrate for lipid peroxidation. Continuing experimental studies in our laboratory clearly show that hepatic steatosis produced by ethanol and a variety of unrelated compounds (amineptine, tetracycline, various tetracycline derivatives, valproic acid, and pirprofen) is associated in each case with increased ethane exhalation in mice. In the present study, a significant relationship was observed between the exhalation of ethane and the semiquantitative estimation of macrovacuolar steatosis (Fig 2) . Taken together, these experimental and human data suggest that the presence of fat deposits in liver cells may be one of the mechanisms leading to lipid peroxidation in alcohol abusers. The correlation with steatosis was very weak, albeit statistically significant (Fig 2), however, suggesting (Table II) . However, because a liver biopsy was not performed in these patients, the Figure 3 : Inverse relationship between the exhalation of ethane, and the duration ofhospital stay in the 89 alcohol abusers (r=correlation coefficient; p=probability), and evolution ofethane exhalation in the nine alcohol abusers who were studied repeatedly. presence of minor liver lesions, such as steatosis, cannot be excluded.
Although the exhalation of ethane was on average increased fivefold in alcohol abusers (Fig 1) , there was wide variability in this group (Table II, Fig 2) . Indeed in a few alcohol abusers, there was no detectable production of ethane (that is, the ethane concentration in expired air was similar to that in inspired air). This variation may reflect both variability in alcohol consumption, in liver lesions, and in the time of measurement, as well as variability in protective mechanisms. Lipid peroxidation is efficiently prevented by vitamin E (catocopherol), which transforms lipid peroxyl radicals into hydroperoxides, the latter being then transformed into lipid alcohols by glutathione peroxidase. In the process, however, a-tocopherol is converted to the a-tocopheroxyl radical, a-tocopheryl quinone, and other products,8 while reduced glutathione (GSH) is oxidised to the disulphide. As a consequence of lipid peroxidation, and other factors, hepatic vitamin E" 12 and GSH levels2 are low in some alcoholics. Depletion of these protective factors may, in turn, permit the unrestrained development of lipid peroxidation in some patients.
Experimentally, lipid peroxidation has several deleterious effects on the liver. It damages membranes, including the plasma membrane, leading to increased entry of calcium into the cell,32 decreased sequestration of calcium in endoplasmic reticulum, and mitochondria,3334 and liberation of lysosomal enzymes.5 Lipid peroxidation activates phospholipase A2, with the release of toxic lysophospholipids, free fatty acids, leukotrienes, and other eicosanoid metabolites.w6 It forms reactive aldehydes (4-hydroxyalkenals and malondialdehyde), which react with hepatic proteins.35 In the present study, however, the exhalation of ethane was similar in patients with cirrhosis and those with other liver lesions (Table II) . Admittedly, progression to cirrhosis should depend not only on the instantaneous degree of a presumed pathogenic event (in this case, lipid peroxidation), but even more on the duration of this process, so that a similar instantaneous value might be seen in patients with incipient lesions and those with full blown cirrhosis. Even in the group of cirrhotic patients, however, ethane exhalation was only weakly correlated with the Pugh's score (Fig 2) . This observation is consistent with the view that many other factors participate in the development of severe liver disease in these patients, including immunological mechanisms, nutritional deficiencies, mitochondrial injury, altered redox status, impaired protein processing, cytoskeletal abnormalities, activation of Ito cells, and circulatory disturbances.3738
In summary, the average exhalation of ethane was increased five-fold in a large hospital series of alcohol abusers, but was normal in a group ofpatients with various non-alcoholic liver diseases. Although the increased exhalation of ethane in alcohol abusers slowly improved after alcohol withdrawal, it was still high during the first week(s) of abstinence, suggesting that it was not related, at that time, to the production of free radicals during the metabolism of ethanol. One of the possible mechanisms may be the presence of increased amounts of oxidisable fat in the liver. The weak correlation with the Pugh's Score in alcoholic patients with cirrhosis is consistent with the contribution of many other factors in the development of severe liver disease in such patients.
